Please set your featured image
New Solid Tumour Profiling Service
OGT predicts patient response to cancer treatment
Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has furthered its commitment to fighting cancer with the launch of a new solid tumor profiling next-generation sequencing service to advance vital research into personalized cancer care. OGT is the first commercial facility in the UK to offer this service.
Read the article in full here